Host: Chongqing Foreign Trade and Economic Relations CommerceUndertaker: Chongqing Investment Promotion Association

Chongqing is an important comprehensive chemical industry base in southwest China. After more than 60 years of development, it has built a natural gasification chemical industry system with technological and product advantages; formed an industrial pattern with longevity and Fuling Chemical Industry Park as the main part, supplemented by other characteristic parks; fostered and developed natural gas chemical industry, salt chemical industry, fine chemical industry, etc. Industrial clusters such as polyurethane. In 2018, there were 287 Chemical Enterprises above the scale in Chongqing's chemical industry, with a total industrial output value of 98.21 billion yuan, an increase of 8.1% over the same period last year.

Through continuous accumulation, innovation and development, a number of leading enterprises have been formed to drive the overall development of Chongqing's chemical industry. The traditional chemical products include two parts: one is the basic chemical products such as triacid, alkali, urea, methanol, and the other is a batch of superior products with domestic influence: potassium permanganate, sodium carboxymethyl cellulose. Vinyl acetate, etc. After many years of development, famous chemical enterprises, such as Basf, BP, Huafeng Chemical Industry in Germany and other countries, have been stationed in Chongqing. The structure of chemical products in Chongqing has changed. Some chemical products with high added value have been produced locally.

Our City promulgated the "Chongqing Municipal People's Government Office's Opinions on Promoting the Structural Adjustment of Chemical Industry, Promoting Transformation and Increasing Benefits" to guide and support the development of chemical industry.

 Chongqing was one of the five major pharmaceutical bases in China. There are 177 regular pharmaceutical enterprises, including 97 enterprises with annual output value of more than 100 million yuan, 12 enterprises with 1 billion yuan and 1 enterprise with 5 billion yuan. There are 10 pharmaceutical enterprises listed on Shanghai and Shenzhen Stock Exchanges, accounting for more than 20% of the listed companies in the whole stock market. In the past five years, our city's biomedical industry has maintained a steady and high-speed growth, with a compound annual growth rate of 19.2%. In 2018, 176 bio-pharmaceutical regulatory enterprises realized a total industrial output value of 61.507 billion yuan, an increase of 11.9% over the previous year, and realized an investment of 7.31 billion yuan in the pharmaceutical industry, an increase of 18.8% over the previous year.

Next, around the two main lines of "encouraging innovation and promoting high-quality development", our city will take the biomedical industry as the innovation leading and breakthrough point of industrial development, and construct a complete industrial ecological system by means of "increasing high-quality varieties, enhancing manufacturing capacity, filling platform shortboard and optimizing industrial layout". Based on the characteristic centralized layout, we will build a national biomedical industrial park. At the same time, we encourage conditional districts and counties (autonomous counties) to lay out a number of characteristic bio-pharmaceutical industrial bases according to local conditions, and form a "1+N" industrial layout.

Following the change of national policy, we should carefully study the development trend of industry, actively promulgate industrial development policies and optimize the industrial development environment. Guidelines for the development of biomedical industry in Chongqing and Some Policies for Accelerating the Development of biomedical industry in Chongqing will be published in the near future.

Host: Chongqing Foreign Trade and Economic Relations CommerceUndertaker: Chongqing Investment Promotion AssociationTel: +86-023-67862888

Wechat QR code

Copyright 2012 All Rights Reserved by Chongqing Foreign Trade and Relations Commision渝ICP备12005872号-5. Prohbited to Copy and any MSL